About OOTR
OOTR is a non-profit international organisation that conducts Translational Research in Asia Pacific, formed by Dr. Louis Chow, a Hong Kong-based breast cancer specialist and Dr. Masakazu Toi, a Japanese-based surgeon-oncologist in the year of 2002. One of the objectives of OOTR is to promote cancer research between Asian and international investigators, and create hope against cancer.
OOTR has now gathered medical professions from different countries such as Japan, Korea, Taiwan, United States and Hong Kong to work together in Translational Research. OOTR also regularly shares the concept of Translational Research and new treatment strategies with clinicians and scientists in international medical conferences. OOTR hopes that through these vital exchanges, new thinking and discoveries will give rise to faster and better ways to fight cancer.
OOTR Hong Kong
Unit A, 9/F, CNT Commercial Building, 302 Queen's Road Central, Hong Kong
Tel: +852 2117 8011
Fax: +852 2117 0021
Email: info@ootr.org
Website: www.ootr.org
Click here to view our new leaflet
OOTR Japan
1F, Kinki District Invention Center14 Yoshida-Kawara-cho, Sakyo-ku Kyoto 606-8305 Japan
Tel: +81-75-761-5717
Fax: +81-75-761-5718
Email: info@ootr-institute.org
Website: www.ootr-institute.org
Sharing
|
|
The Honourable Mrs. Rita Fan GBM, GBS, CBE, JP Hong Kong Deputy to the National People's Congress of the People's Republic of China "The purpose of finding new treatment approach is to lessen the patients’ trauma and suffering. I think patients, doctors and researchers should work together." |
|
Prof. Louis W.C. Chow Founder and Executive Director, OOTR "Translational Research is to transform laboratory results into clinical application. |
|
|
|
Prof. Masakazu Toi Founder & President, OOTR "Translational Research transmits new cancer therapeutics or cancer diagnosis from basic science to clinical science. OOTR calls on as many people as possibleto work together in cancer treatment research."
|
|
Prof. Stefan Glück University of Miamia, USA "The anticipated progress in breast cancer treatment mainly relies on |
|
|
|
Prof. Yihai Cao Microbiology and Tumor Biology Centre, Karolinska Institute, Sweden "Translational Research perhaps is the most important part in bio-medical research. We really need to fill the gap between clinical research and basic research." |
|
Prof. Nadir Arber Cancer Prevention Unit, Tel-Aviv Sourasky Medical Center, Israel "When we can learn about and know the strategy of patient treatment, we can |
|
|
|
Prof. Yan Sun Chinese Academy of Medical Sciences, Chinese Academy of Engineering "Although clinical oncology developing rapidly in Asia during the post 20 years, it becomes more and more important to follow the up-dated development world-wide. We all aware that standard multi-disciplinary treatment and individualization based on the most recent evidence are trends of clinical medicine."
|
|
Prof. Giuseppe Viale European Institute of Oncology "The role of translational research in the process of improving personalised
|
|
|
|
Prof. Aaron Ciechanover Nobel Prize laureate in Chemistry "Translational research means that we translate basic biomedical knowledge, the understanding of the underlying complex mechanisms of diseases into the useful language of drug and vice development. Thus, basic and translational research go hand by hand, as the one cannot exist without the other." |












